Accession Number: | 0001144204-19-026662 |
Date: | 2019-05-13 |
Issuer: | ANI PHARMACEUTICALS INC (ANIP) |
Original Submission Date: |
PRZYBYL ARTHUR
C/O ANI PHARMACEUTICALS, INC.
210 MAIN STREET WEST
BAUDETTE, MN 56623
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2019-05-13 | S | 9,595 | d | $71.10 | 222,994 | direct | ||
COMMON STOCK | 2019-05-14 | S | 5,772 | d | $70.45 | 217,222 | direct | ||
COMMON STOCK | 2019-05-15 | S | 14,633 | d | $69.25 | 202,589 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|